✦ LIBER ✦

Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study

✍ Scribed by Anneke Q. van Hoesel, Cornelis J. H. van de Velde, Peter J. K. Kuppen, Gerrit Jan Liefers, Hein Putter, Yusuke Sato, David A. Elashoff, Roderick R. Turner, Jaime M. Shamonki, Esther M. de Kruijf, Johanna G. H. van Nes, Armando E. Giuliano, Dave S. B. Hoon

Book ID: 118796627
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 315 KB
Volume: 134
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-2038-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tissue inhibitor of metalloproteinases-1

Tissue inhibitor of metalloproteinases-1 (TIMP-1) and prognosis in primary breast cancer: an EORTC—RBG collaborative validation study including 2984 patients

✍ A Schrohl; M.N Holten-Andersen; H.A Peters; M.P Look; M.E Meijer-van Gelder; J.G 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Overexpression of CXCR4 in Primary Tumor

Overexpression of CXCR4 in Primary Tumor of Patients with HER-2 Negative Breast Cancer was Predictive of a Poor Disease-Free Survival: A Validation Study

✍ Jason Mizell; Mark Smith; Benjamin D. L. Li; Fred Ampil; Quyen D. Chu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 283 KB

Prognostic significance of RACGAP1 mRNA

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

✍ K. Pliarchopoulou, K. T. Kalogeras, R. Kronenwett… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 321 KB

The risk of contralateral breast cancer

The risk of contralateral breast cancer in patients fromBRCA1/2negative high risk families as compared to patients fromBRCA1orBRCA2positive families: a retrospective cohort study

✍ Kerstin Rhiem, Christoph Engel, Monika Graeser, Silke Zachariae, Karin Kast, Mar 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 487 KB

Tumor tissue levels of Tissue Inhibitor

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

✍ Anne-Sofie Schrohl; Maxime P Look; Marion E Meijer-van Gelder; John A Foekens; N 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 313 KB

The mTOR effectors 4EBP1 and S6K2 are fr

The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials

✍ Karlsson, Elin; Pérez-Tenorio, Gizeh; Amin, Risul; Bostner, Josefine; Skoog, Lam 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 402 KB